Malignant News and Research

RSS

Tiny gold nanotubes could help treat mesothelioma

Gold nanotubes - tiny hollow cylinders one thousandth the width of a human hair - could be used to treat mesothelioma, a type of cancer caused by exposure to asbestos, according to a team of researchers at the Universities of Cambridge and Leeds.

27 Oct 2020

Scientists identify new target for developing novel drugs against several types of cancer

The Bcl-2 protein family comprises anti- and proapoptotic members, i.e. they protect the cell from death or favour it.

27 Oct 2020

Researchers find a new therapeutic approach to combat leukemia

Leukemia frequently originates from the so-called leukemic stem cell, which resides in a tumor promoting and protecting niche within the bone marrow. Scientists from the Max Planck Institute of Biochemistry in Martinsried, Germany, have found a new way to make these cells vulnerable by specifically dislodging these cells from their niches.

23 Oct 2020

Researchers find an increasing need for palliative care across Greater China

Palliative care should extend across China and pay more attention to managing non-malignant disease - integrated within the country's healthcare system and available to everyone who needs it, according to a new study.

21 Oct 2020

Researchers successfully perform terahertz imaging of early-stage breast cancer without staining

A team of researchers at Osaka University, in collaboration with the University of Bordeaux and the Bergonié Institute in France, has succeeded in terahertz imaging of early-stage breast cancer less than 0.5 mm without staining, which is difficult to identify even by pathological diagnosis.

21 Oct 2020

UCLA professor named to the National Academy of Medicine

Dr. Antoni Ribas, a world-renowned physician-scientist and professor of medicine at the David Geffen School of Medicine at UCLA, has been named to the National Academy of Medicine, one of the highest honors in the fields of health and medicine.

19 Oct 2020

Researchers develop breakthrough blood test for brain tumors

Genetic mutations that promote the growth of the most common type of adult brain tumors can be accurately detected and monitored in blood samples using an enhanced form of liquid biopsy developed by researchers at Massachusetts General Hospital.

14 Oct 2020

Study uncovers the mechanism behind bone marrow failure in Fanconi anemia

Fanconi anaemia (FA) is a genetic disease affecting small children characterized by bone-marrow failure, developmental abnormalities and predisposition to multiple forms of cancer.

14 Oct 2020

3D structural model of BAF complex modifies DNA architecture, provides clues on cancer

Scientists have created an unprecedented 3-dimensional structural model of a key molecular "machine" known as the BAF complex, which modifies DNA architecture and is frequently mutated in cancer and some other diseases.

14 Oct 2020

Researchers are developing a new class of compounds against various cancers

Researchers at The Wistar Institute and collaborators from the University of Notre Dame are developing anticancer compounds targeting a pathway of the endoplasmic reticulum (ER) stress response implicated in the development of multiple myeloma (MM), chronic lymphocytic leukemia (CLL) and lymphoma.

14 Oct 2020

Study shows how mutations in VAV1 gene may promote T-cell tumors in experimental mice

Life is an exquisite orchestration of growth and change, with checks and balances that fine-tune complex entwined interactions, both intrinsic and external.

12 Oct 2020

Developing a precision 'Trojan Horse' nanotherapy to treat breast cancer

With a nearly $2.6 million grant from the National Institutes of Health, Michigan State University researchers are using nanoscopic particles to turn the body's own cells into weapons that cancer won't see coming.

9 Oct 2020

Hypoxic exosomes promote stemness in EWS sarcoma, indicates study

The cover for issue 40 of Oncotarget features Figure 5, "miR-210 silences the proapoptosis member CASP8AP2," by Kling, et al. which reported that hypoxic Ewing's sarcoma cells release exosomes that promote sphere formation, a stem-like phenotype, in EWS cells by enhancing survival.

9 Oct 2020

Study: Thymoquinone selectively kills prostate cancer cells at advanced stages

The compound thymoquinone (TQ) selectively kills prostate cancer cells at advanced stages, according to a new study published in Oncogene.

8 Oct 2020

UM associate professor wins multiple awards for ear, skin science

University of Montana scientist Monica Serban is on a research roll. In recent months the UM associate professor and her team have earned three awards totaling $3.9 million in funding to study preventing hearing loss among U.S. troops, combating ear infections and creating a synthetic skin product.

6 Oct 2020

Malignant News and Research

Tiny gold nanotubes could help treat mesothelioma

Scientists identify new target for developing novel drugs against several types of cancer

Researchers find a new therapeutic approach to combat leukemia

Researchers find an increasing need for palliative care across Greater China

Researchers successfully perform terahertz imaging of early-stage breast cancer without staining

UCLA professor named to the National Academy of Medicine

Researchers develop breakthrough blood test for brain tumors

Study uncovers the mechanism behind bone marrow failure in Fanconi anemia

3D structural model of BAF complex modifies DNA architecture, provides clues on cancer

Researchers are developing a new class of compounds against various cancers

Study shows how mutations in VAV1 gene may promote T-cell tumors in experimental mice

Developing a precision 'Trojan Horse' nanotherapy to treat breast cancer

Hypoxic exosomes promote stemness in EWS sarcoma, indicates study

Study: Thymoquinone selectively kills prostate cancer cells at advanced stages

UM associate professor wins multiple awards for ear, skin science

Survival probabilities are higher in patients who underwent complex pancreatic surgery

Direction and type of the force acting on a cell can alter gene expression

Researchers unravel new mechanism of cell survival in chronic lymphocytic leukemia

Skoltech researchers identify new panel of potential biomarkers for liver cancer diagnosis

New FLASH technique could revolutionize radiation therapy for cancer patients

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News